Scottie Kern
Eli Lilly (United States)(US)Critical Path Institute(US)
Publications by Year
Research Areas
Electronic Health Records Systems, Health Systems, Economic Evaluations, Quality of Life, Statistical Methods in Clinical Trials, Digital Mental Health Interventions, Cancer survivorship and care
Most-Cited Works
- → Recommendations to address respondent burden associated with patient-reported outcome assessment(2024)94 cited
- → Validation of Electronic Systems to Collect Patient-Reported Outcome (PRO) Data—Recommendations for Clinical Trial Teams: Report of the ISPOR ePRO Systems Validation Good Research Practices Task Force(2013)92 cited
- → Best Practice Recommendations for Electronic Patient-Reported Outcome Dataset Structure and Standardization to Support Drug Development(2023)12 cited
- → Implementing sensor‐based digital health technologies in clinical trials: Key considerations from the eCOA Consortium(2024)6 cited
- → Best Practice Recommendations for Electronic Clinical Outcome Assessment Data Changes(2023)3 cited
- → Flexible approaches to eCOA administration in clinical trials: The site perspective(2023)3 cited
- → Advancing the Integration of Digital Health Technologies in the Drug Development Ecosystem(2025)1 cited
- → Best practice recommendations and considerations for designing and electronically implementing event-driven diaries in clinical trials(2025)1 cited
- → Advancing the Integration of Digital Health Technologies in the Drug Development Ecosystem (Preprint)(2024)
- Валидация электронных систем сбора данных «Оценок Результатов Пациентами» — Рекомендации для клинических исследователей: отчёт Целевой Группы ISPOR по надлежащей исследовательской практике валидации ePRO систем(2015)